Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL306015 | 1.00 | L3MBTL1 (0.32) | L3MBTL1PDE4A | |
| SCHEMBL4439438 | 1.00 | L3MBTL1 (0.32) | L3MBTL1PDE4A | |
| Water SCHEMBL15482324 | 0.98 | L3MBTL1 (0.31) | L3MBTL1 | |
| SCHEMBL27044970 | 0.87 | PNP (0.31) | — | |
| SCHEMBL13372164 | 0.85 | L3MBTL1 (0.32) | L3MBTL1 | |
| Lx-2931 SCHEMBL304964 | 0.82 | L3MBTL1 (0.33) | L3MBTL1 | |
| Lx-2931 SCHEMBL20744226 | 0.82 | L3MBTL1 (0.33) | L3MBTL1 | |
| Lx-2931 SCHEMBL304963 | 0.82 | L3MBTL1 (0.33) | L3MBTL1 | |
| Lx-2931 SCHEMBL316870 | 0.82 | L3MBTL1 (0.33) | L3MBTL1 | |
| Lx-2931 SCHEMBL20744228 | 0.82 | L3MBTL1 (0.33) | L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3668506-B1 | ENHANCEMENT OF CANCER TREATMENT EFFICIENCY VIA THE SPHINGOSINE-1-PHOSPHATE PATHWAY | AC BIOSCIENCE (CH) | 2023-12-06 | — | — | EP | claimed |
| EP-4017844-B1 | COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF INFECTIOUS DISEASES AND CANCER | AC BIOSCIENCE SA (CH) | 2024-01-24 | — | — | EP | disclosed |
| CN-115058468-B | Schizophyllan compound polysaccharide, ion-reduced transdermal toning lotion and preparation method thereof | 宁波泉水生物科技有限公司 | 2023-04-28 | — | — | CN | disclosed |
| US-20220306587-A1 | COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF INFECTIOUS DISEASES AND CANCER | AC BIOSCIENCE SA (CH) | 2022-09-29 | — | — | US | disclosed |
| CN-115058468-A | Schizophyllin compound polysaccharide, ion reduction transdermal toning lotion and preparation method thereof | 宁波泉水生物科技有限公司 | 2022-09-16 | — | — | CN | disclosed |
| CN-114555567-A | Compounds and their use for the treatment of infectious diseases and cancer | AC生命科学有限公司 | 2022-05-27 | — | — | CN | disclosed |
| EP-3286301-B1 | GENERATION OF MUSCLE-LINEAGE CELLS FROM STEM CELLS | SONIC MASTER LTD (VG) | 2021-07-28 | — | — | EP | disclosed |
| EP-2090334-B1 | Imidazole based compounds, compositions comprising them and methods of their use | LEXICON PHARMACEUTICALS INC (US) | 2015-04-29 | — | — | EP | disclosed |
| CN-102648185-A | Methods of preparing 1-(4-((1r,2s,3r)-1,2,3,4-tetrahydroxybutyl)-1h-imidazol-2-yl)ethanone | LEXICON PHARMACEUTICALS INC | 2012-08-22 | — | — | CN | disclosed |
| EP-2090334-A2 | Imidazole based compounds, compositions comprising them and methods of their use | Lexicon Pharmaceuticals, Inc. (US) | 2009-08-19 | — | — | EP | disclosed |
| US-20080248032-A1 | Using 2-acetyl-4-tetrahydroxybutylimidazole (THI) as therapeutic in treatment and prevention of heart and stroke injury | CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND (US) | 2008-10-09 | — | — | US | disclosed |
| US-20080248032-A1 | Using 2-acetyl-4-tetrahydroxybutylimidazole (THI) as therapeutic in treatment and prevention of heart and stroke injury | CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND (US) | 2008-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220306587-A1 | COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF INFECTIOUS DISEASES AND CANCER | SGPL1, SPHK1, S1PR1 | L3MBTL1 256/4885PDE4A 1103/4885 |
| US-20080248032-A1 | Using 2-acetyl-4-tetrahydroxybutylimidazole (THI) as therapeutic in treatment and prevention of heart and stroke injury | SPHK1, SPHK2, SPTLC1 | L3MBTL1 268/4885PDE4A 1328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.